Hugh Young Rienhoff
Founder chez IMAGO BIOSCIENCES, INC.
Profil
Hugh Young Rienhoff was the founder of DNA Sciences, Inc. (founded in 1998) where he served as Chairman & Chief Executive Officer from 1998 to 2001.
He was also the founder of FerroKin BioSciences, Inc. (founded in 2007) where he held the position of Chief Executive Officer from 2007 to 2012.
Additionally, he is the founder of Imago BioSciences, Inc. (founded in 2012) where he currently serves as Chief Executive Officer.
In his current roles, Dr. Rienhoff is the Chairman of Odyssey Thera, Inc., Parvus Therapeutics, Inc., and Datahooks, Inc. He is also a Director at Attenua, Inc., an Advisor at HealthCap AB, and an Adjunct Scientist at Children's Hospital Oakland Research Institute.
Dr. Rienhoff has held former positions as Chairman of Wilson Therapeutics AB, Founding Director of Aurora Biosciences Corp., Director of Emdeon Corp., Director of Iconix Biosciences, Inc., Founding Director of WebMD, Inc., Director of Peptimmune, Inc., Director of Hydra Biosciences, Inc., Director of Abingworth Management, Inc., Director of Mydaughtersdna, Partner at NEA Management Co. LLC, and Faculty Member at The Johns Hopkins University.
Dr. Rienhoff obtained a doctorate degree from The Johns Hopkins University and an undergraduate degree from Williams College.
Postes actifs de Hugh Young Rienhoff
| Sociétés | Poste | Début |
|---|---|---|
| IMAGO BIOSCIENCES, INC. | Founder | 01/03/2012 |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Consultant / Advisor | - |
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Director/Board Member | - |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Chairman | 16/07/2019 |
| Datahooks, Inc. | Director/Board Member | - |
Children's Hospital Oakland Research Institute
 Children's Hospital Oakland Research Institute Hospital/Nursing ManagementHealth Services Children's Hospital Oakland Research Institute operates as a biomedical research institute of Children's Hospital and Research Center. The private company is based in Oakland, CA. | Corporate Officer/Principal | - |
Odyssey Thera, Inc.
 Odyssey Thera, Inc. Pharmaceuticals: MajorHealth Technology Odyssey Thera, Inc. operates as a biopharmaceutical company. The company was founded by John Westwick and Stephen W. Michnick in 2000 and is headquartered in San Ramon, CA. | Chairman | - |
Anciens postes connus de Hugh Young Rienhoff
| Sociétés | Poste | Fin |
|---|---|---|
| WILSON THERAPEUTICS AB | Chairman | 20/10/2015 |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Chief Executive Officer | 01/01/2012 |
| ░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Hugh Young Rienhoff
| The Johns Hopkins University | Doctorate Degree |
| Williams College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
Emdeon Corp.
 Emdeon Corp. Data Processing ServicesTechnology Services Emdeon Corp. offers services to connect physicians, hospitals, pharmacies, insurance providers, and consumers with health care transactions and information retrieval. Its transaction services encompass such tasks as HMO enrollment, referrals, data retrieval, and claims processing; its Medical Manager software helps physicians run their practices. The company was founded in December 1995 and is headquartered in Elmwood Park, NJ. | Technology Services |
DNA Sciences, Inc.
 DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a private company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Health Technology |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | Health Technology |
| Datahooks, Inc. | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Finance |
WebMD, Inc.
 WebMD, Inc. Internet Software/ServicesTechnology Services WebMD, Inc. provides Internet-based services and information for physicians and health care information services for consumers | Technology Services |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | Health Technology |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Finance |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Health Technology |
Odyssey Thera, Inc.
Odyssey Thera, Inc. Pharmaceuticals: MajorHealth Technology Odyssey Thera, Inc. operates as a biopharmaceutical company. The company was founded by John Westwick and Stephen W. Michnick in 2000 and is headquartered in San Ramon, CA. | Health Technology |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Children's Hospital Oakland Research Institute
Children's Hospital Oakland Research Institute Hospital/Nursing ManagementHealth Services Children's Hospital Oakland Research Institute operates as a biomedical research institute of Children's Hospital and Research Center. The private company is based in Oakland, CA. | Health Services |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
Attenua, Inc.
Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Health Technology |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
| Mydaughtersdna |
